These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30777112)

  • 21. Feasibility, acceptability and impact of integrating malaria rapid diagnostic tests and pre-referral rectal artesunate into the integrated community case management programme. A pilot study in Mchinji district, Malawi.
    Phiri TB; Kaunda-Khangamwa BN; Bauleni A; Chimuna T; Melody D; Kalengamaliro H; Sande JH; Nsona HK; Mathanga DP
    Malar J; 2016 Mar; 15():177. PubMed ID: 27000034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment-seeking behaviour and associated costs for malaria in Papua, Indonesia.
    Karyana M; Devine A; Kenangalem E; Burdarm L; Poespoprodjo JR; Vemuri R; Anstey NM; Tjitra E; Price RN; Yeung S
    Malar J; 2016 Nov; 15(1):536. PubMed ID: 27821127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of sudden unexplained death after use of dihydroartemisinin-piperaquine for malaria: a systematic review and Bayesian meta-analysis.
    Chan XHS; Win YN; Mawer LJ; Tan JY; Brugada J; White NJ
    Lancet Infect Dis; 2018 Aug; 18(8):913-923. PubMed ID: 29887371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of intermittent preventive treatment and intermittent screening and treatment versus single screening and treatment with dihydroartemisinin-piperaquine for the control of malaria in pregnancy in Indonesia: a cluster-randomised, open-label, superiority trial.
    Ahmed R; Poespoprodjo JR; Syafruddin D; Khairallah C; Pace C; Lukito T; Maratina SS; Asih PBS; Santana-Morales MA; Adams ER; Unwin VT; Williams CT; Chen T; Smedley J; Wang D; Faragher B; Price RN; Ter Kuile FO
    Lancet Infect Dis; 2019 Sep; 19(9):973-987. PubMed ID: 31353217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 'Some anti-malarials are too strong for your body, they will harm you.' Socio-cultural factors influencing pregnant women's adherence to anti-malarial treatment in rural Gambia.
    Jaiteh F; Dierickx S; Gryseels C; O'Neill S; D'Alessandro U; Scott S; Balen J; Grietens KP
    Malar J; 2016 Apr; 15():195. PubMed ID: 27068760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intermittent preventive treatment with dihydroartemisinin-piperaquine and risk of malaria following cessation in young Ugandan children: a double-blind, randomised, controlled trial.
    Muhindo MK; Jagannathan P; Kakuru A; Opira B; Olwoch P; Okiring J; Nalugo N; Clark TD; Ruel T; Charlebois E; Feeney ME; Havlir DV; Dorsey G; Kamya MR
    Lancet Infect Dis; 2019 Sep; 19(9):962-972. PubMed ID: 31307883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Community Lab of Ideas for Health: Community-Based Transdisciplinary Solutions in a Malaria Elimination Trial in The Gambia.
    Masunaga Y; Jaiteh F; Manneh E; Balen J; Okebe J; D'Alessandro U; Nieto-Sanchez C; de Vries DH; Gerrets R; Peeters Grietens K; Muela Ribera J
    Front Public Health; 2021; 9():637714. PubMed ID: 34354972
    [No Abstract]   [Full Text] [Related]  

  • 28. Mass drug administration of ivermectin and dihydroartemisinin-piperaquine against malaria in settings with high coverage of standard control interventions: a cluster-randomised controlled trial in The Gambia.
    Dabira ED; Soumare HM; Conteh B; Ceesay F; Ndiath MO; Bradley J; Mohammed N; Kandeh B; Smit MR; Slater H; Peeters Grietens K; Broekhuizen H; Bousema T; Drakeley C; Lindsay SW; Achan J; D'Alessandro U
    Lancet Infect Dis; 2022 Apr; 22(4):519-528. PubMed ID: 34919831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and efficacy of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnant women with HIV from Gabon and Mozambique: a randomised, double-blind, placebo-controlled trial.
    González R; Nhampossa T; Mombo-Ngoma G; Mischlinger J; Esen M; Tchouatieu AM; Mendes A; Figueroa-Romero A; Zoleko-Manego R; Lell B; Lagler H; Stoeger L; Dimessa LB; El Gaaloul M; Sanz S; Méndez S; Piqueras M; Sevene E; Ramharter M; Saúte F; Menendez C;
    Lancet Infect Dis; 2024 May; 24(5):476-487. PubMed ID: 38224706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-Effectiveness of Focal Mass Drug Administration and Mass Drug Administration with Dihydroartemisinin-Piperaquine for Malaria Prevention in Southern Province, Zambia: Results of a Community-Randomized Controlled Trial.
    Yukich JO; Scott C; Silumbe K; Larson BA; Bennett A; Finn TP; Hamainza B; Conner RO; Porter TR; Keating J; Steketee RW; Eisele TP; Miller JM
    Am J Trop Med Hyg; 2020 Aug; 103(2_Suppl):46-53. PubMed ID: 32618249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and mosquitocidal efficacy of high-dose ivermectin when co-administered with dihydroartemisinin-piperaquine in Kenyan adults with uncomplicated malaria (IVERMAL): a randomised, double-blind, placebo-controlled trial.
    Smit MR; Ochomo EO; Aljayyoussi G; Kwambai TK; Abong'o BO; Chen T; Bousema T; Slater HC; Waterhouse D; Bayoh NM; Gimnig JE; Samuels AM; Desai MR; Phillips-Howard PA; Kariuki SK; Wang D; Ward SA; Ter Kuile FO
    Lancet Infect Dis; 2018 Jun; 18(6):615-626. PubMed ID: 29602751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chloroquine Versus Dihydroartemisinin-Piperaquine With Standard High-dose Primaquine Given Either for 7 Days or 14 Days in Plasmodium vivax Malaria.
    Chu CS; Phyo AP; Turner C; Win HH; Poe NP; Yotyingaphiram W; Thinraow S; Wilairisak P; Raksapraidee R; Carrara VI; Paw MK; Wiladphaingern J; Proux S; Bancone G; Sriprawat K; Lee SJ; Jeeyapant A; Watson J; Tarning J; Imwong M; Nosten F; White NJ
    Clin Infect Dis; 2019 Apr; 68(8):1311-1319. PubMed ID: 30952158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison.
    Ratcliff A; Siswantoro H; Kenangalem E; Maristela R; Wuwung RM; Laihad F; Ebsworth EP; Anstey NM; Tjitra E; Price RN
    Lancet; 2007 Mar; 369(9563):757-765. PubMed ID: 17336652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variable piperaquine exposure significantly impacts protective efficacy of monthly dihydroartemisinin-piperaquine for the prevention of malaria in Ugandan children.
    Sundell K; Jagannathan P; Huang L; Bigira V; Kapisi J; Kakuru MM; Savic R; Kamya MR; Dorsey G; Aweeka F
    Malar J; 2015 Sep; 14():368. PubMed ID: 26403465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Foul wind, spirits and witchcraft: illness conceptions and health-seeking behaviour for malaria in the Gambia.
    O'Neill S; Gryseels C; Dierickx S; Mwesigwa J; Okebe J; d'Alessandro U; Peeters Grietens K
    Malar J; 2015 Apr; 14():167. PubMed ID: 25908392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial.
    van der Pluijm RW; Tripura R; Hoglund RM; Pyae Phyo A; Lek D; Ul Islam A; Anvikar AR; Satpathi P; Satpathi S; Behera PK; Tripura A; Baidya S; Onyamboko M; Chau NH; Sovann Y; Suon S; Sreng S; Mao S; Oun S; Yen S; Amaratunga C; Chutasmit K; Saelow C; Runcharern R; Kaewmok W; Hoa NT; Thanh NV; Hanboonkunupakarn B; Callery JJ; Mohanty AK; Heaton J; Thant M; Gantait K; Ghosh T; Amato R; Pearson RD; Jacob CG; Gonçalves S; Mukaka M; Waithira N; Woodrow CJ; Grobusch MP; van Vugt M; Fairhurst RM; Cheah PY; Peto TJ; von Seidlein L; Dhorda M; Maude RJ; Winterberg M; Thuy-Nhien NT; Kwiatkowski DP; Imwong M; Jittamala P; Lin K; Hlaing TM; Chotivanich K; Huy R; Fanello C; Ashley E; Mayxay M; Newton PN; Hien TT; Valecha N; Smithuis F; Pukrittayakamee S; Faiz A; Miotto O; Tarning J; Day NPJ; White NJ; Dondorp AM;
    Lancet; 2020 Apr; 395(10233):1345-1360. PubMed ID: 32171078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of targeted malaria elimination with mass drug administrations on falciparum malaria in Southeast Asia: A cluster randomised trial.
    von Seidlein L; Peto TJ; Landier J; Nguyen TN; Tripura R; Phommasone K; Pongvongsa T; Lwin KM; Keereecharoen L; Kajeechiwa L; Thwin MM; Parker DM; Wiladphaingern J; Nosten S; Proux S; Corbel V; Tuong-Vy N; Phuc-Nhi TL; Son DH; Huong-Thu PN; Tuyen NTK; Tien NT; Dong LT; Hue DV; Quang HH; Nguon C; Davoeung C; Rekol H; Adhikari B; Henriques G; Phongmany P; Suangkanarat P; Jeeyapant A; Vihokhern B; van der Pluijm RW; Lubell Y; White LJ; Aguas R; Promnarate C; Sirithiranont P; Malleret B; Rénia L; Onsjö C; Chan XH; Chalk J; Miotto O; Patumrat K; Chotivanich K; Hanboonkunupakarn B; Jittmala P; Kaehler N; Cheah PY; Pell C; Dhorda M; Imwong M; Snounou G; Mukaka M; Peerawaranun P; Lee SJ; Simpson JA; Pukrittayakamee S; Singhasivanon P; Grobusch MP; Cobelens F; Smithuis F; Newton PN; Thwaites GE; Day NPJ; Mayxay M; Hien TT; Nosten FH; Dondorp AM; White NJ
    PLoS Med; 2019 Feb; 16(2):e1002745. PubMed ID: 30768615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. User and Provider Acceptability of Intermittent Screening and Treatment and Intermittent Preventive Treatment with Dihydroartemisinin-Piperaquine to Prevent Malaria in Pregnancy in Western Kenya.
    Hill J; Hoyt J; Achieng F; Ouma P; L'lanziva A; Kariuki S; Desai M; Webster J
    PLoS One; 2016; 11(3):e0150259. PubMed ID: 26986471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria during pregnancy and risk of malaria in early childhood: A randomized controlled trial.
    Jagannathan P; Kakuru A; Okiring J; Muhindo MK; Natureeba P; Nakalembe M; Opira B; Olwoch P; Nankya F; Ssewanyana I; Tetteh K; Drakeley C; Beeson J; Reiling L; Clark TD; Rodriguez-Barraquer I; Greenhouse B; Wallender E; Aweeka F; Prahl M; Charlebois ED; Feeney ME; Havlir DV; Kamya MR; Dorsey G
    PLoS Med; 2018 Jul; 15(7):e1002606. PubMed ID: 30016328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative study of the efficacy and tolerability of dihydroartemisinin-piperaquine-trimethoprim versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Cameroon, Ivory Coast and Senegal.
    Menan H; Faye O; Same-Ekobo A; Oga AS; Faye B; Kiki Barro CP; Kuete T; N'diaye JL; Vicky AM; Tine R; Yavo W; Kane D; Kassi KF; Kone M
    Malar J; 2011 Jul; 10():185. PubMed ID: 21740570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.